Form 4 for CRMD CorMedix Inc.
Accepted 2023-05-17 00:00:00 ET · period of report 2023-05-17 · accession 0000929638-23-001517 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-17 | 2023-05-17 | CRMD | Todisco Joseph | CEO, Dir | A - Grant | $4.58 | +5,000 | 209.7K | +2% | +$22.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-17 | A | A | 5,000 | $4.58 | 209,726 | D | — | — |